homocysteine has been researched along with Left Ventricular Hypertrophy in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.45) | 18.2507 |
2000's | 16 (55.17) | 29.6817 |
2010's | 9 (31.03) | 24.3611 |
2020's | 3 (10.34) | 2.80 |
Authors | Studies |
---|---|
Li, H; Li, P; Lin, BY; Wu, XD; Zeng, ZY | 1 |
Chen, Y; Guo, X; Sun, Y; Yang, H; Yu, S; Zheng, L | 1 |
Kozakova, M; Morizzo, C; Nilsson, J; Palombo, C; Penno, G; Shore, AC | 1 |
Il'icheva, OE; Kharlamova, UV | 1 |
Assareh, H; Jelinek, H; Ke, H; Leng, YLY; McCabe, J; McLachlan, CS; Zhou, Y | 1 |
Li, Y; Lou, T; Ma, X; Peng, H; Wang, C; Ye, Z; Zhang, J; Zhang, Q | 1 |
Chen, J; Hughes, WM; Kang, YJ; Moshal, KS; Rodriguez, WE; Rosenberger, D; Sen, U; Tyagi, N; Tyagi, SC; Vacek, T | 1 |
Kumar, M; Kundu, S; Lominadze, D; Metreveli, N; Mishra, PK; Rodriguez, W; Sen, U; Tyagi, N; Tyagi, SC | 1 |
Alter, P; Figiel, JH; Klose, KJ; Maisch, B; Renz, H; Rominger, MB; Rupp, H | 1 |
Kaur, T; Pal Singh, A; Singh Bedi, PM; Singh, N; SinghDahiya, R | 1 |
Sarnak, MJ; Shastri, S | 1 |
Bhandari, S | 1 |
Micozkadıoğlu, H; Ozelsancak, R; Torun, D; Yiğit, F | 1 |
Ding, G; Ma, T | 1 |
Berent, H; Kostrubiec, M; Kuch-Wocial, A; Kuczyńska, K; Niewegłowska, N; Wocial, B | 1 |
Busch, M; Franke, S; Kientsch-Engel, R; Müller, A; Sommer, M; Stein, G | 1 |
Landray, MJ; Townend, JN; Wheeler, DC | 1 |
Cases, A | 1 |
Chan, IH; Lam, CW; Li, PK; Lui, SF; Sanderson, JE; Wang, AY; Wang, M; Woo, J | 1 |
Altun, B; Arici, M; Bakkaloğlu, M; Gençtoy, G; Hayran, M; Kahraman, S; Onalan, O; Oto, A; Turgan, C; Yasavul, U; Yilmaz, R | 1 |
Fort, J | 1 |
Antoniewicz, J; Daszkowska, J; Grenda, R; Litwin, M; Niemirska, A; Sladowska, J; Wawer, ZT; Wierzbicka, A | 1 |
Aksoy, Y; Aydogdu, I; Kosar, F; Sahin, I; Senel, S; Taskapan, H; Taskapan, MC; Ulutas, O | 1 |
Abu-Hijleh, M; Garadah, T; Golbahar, J; Gumaa, K; Kassab, S; Senok, S; Wazir, J | 1 |
Antoniewicz, J; Daszkowska, J; Litwin, M; Niemirska, A; Sladowska, J; Syczewska, M; Wawer, ZT; Wierzbicka, A | 1 |
Harjai, KJ | 1 |
Beevers, DG; Blann, AD; Edmunds, E; Jones, AF; Lip, GY; Martin, SC | 1 |
Baigent, C; Jones, HJ; Kendall, MJ; Landray, MJ; McGlynn, FJ; Thambyrajah, J; Townend, JN; Wheeler, DC | 1 |
Bower, JD; Miller, A; Mujumdar, V; Palmer, L; Tyagi, SC | 1 |
4 review(s) available for homocysteine and Left Ventricular Hypertrophy
Article | Year |
---|---|
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease.
Topics: Albuminuria; Anemia, Iron-Deficiency; Calcium Phosphates; Carnitine; Heart Failure; Homocysteine; Humans; Hypertrophy, Left Ventricular; Hyperuricemia; Insulin Resistance; Kidney Failure, Chronic; Lipid Metabolism Disorders; Myocarditis; Oxidative Stress; Proteinuria; Risk Factors; Vitamin D Deficiency | 2011 |
[New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen].
Topics: Atrial Fibrillation; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Obesity; Risk Factors; Smoking | 2004 |
Chronic renal failure: a cardiovascular risk factor.
Topics: Albuminuria; Anemia; Calcinosis; Cardiovascular Diseases; Glomerular Filtration Rate; Homocysteine; Humans; Hypertrophy, Left Ventricular; Inflammation; Kidney; Kidney Failure, Chronic; Metabolic Syndrome; Oxidative Stress; Prevalence; Risk Factors; Sympathetic Nervous System; Uremia | 2005 |
Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.
Topics: Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypertrophy, Left Ventricular; Lipoprotein(a); Oxidative Stress; Risk Factors; Triglycerides | 1999 |
25 other study(ies) available for homocysteine and Left Ventricular Hypertrophy
Article | Year |
---|---|
The Relationship Between Homocysteine, Blood Pressure Variability, and Left Ventricular Hypertrophy in Patients with Essential Hypertension: An Observational Study.
Topics: Adult; Blood Pressure; Essential Hypertension; Female; Homocysteine; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged | 2020 |
Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese.
Topics: Adult; Biomarkers; China; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Metabolic Syndrome; Middle Aged; Prevalence; Risk Assessment; Risk Factors; Rural Health; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
Topics: Adult; Aged; Ankle Brachial Index; Biomarkers; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Diabetes Mellitus; Dyslipidemias; Echocardiography; Female; Homocysteine; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Plaque, Atherosclerotic; Prevalence; Pulse Wave Analysis; Risk Factors; Vascular Stiffness | 2020 |
[Effect of homocysteine on left ventricular structural and functional parameters in patients on programmed hemodialysis].
Topics: Adult; Female; Heart Ventricles; Homocysteine; Humans; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Middle Aged; Renal Dialysis; Structure-Activity Relationship; Ultrasonography; Ventricular Remodeling | 2013 |
Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population.
Topics: Age Factors; Aged; Australia; Body Mass Index; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Electrocardiography; Exercise; Female; Homocysteine; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Retrospective Studies; Risk Factors; Rural Population; Sex Factors; Smoking | 2015 |
High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.
Topics: Adult; Calcium Phosphates; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Incidence; Kidney; Linear Models; Male; Middle Aged; Prevalence; Renal Insufficiency, Chronic; Risk Factors; Serum Albumin; Sex Factors; Uric Acid; Ventricular Dysfunction, Left | 2016 |
Role of copper and homocysteine in pressure overload heart failure.
Topics: Animals; Aorta; Blood Pressure; Blotting, Western; Cardiomyopathy, Dilated; Constriction; Copper; Dietary Supplements; Disease Models, Animal; Echocardiography; Electrocardiography; Endothelium, Vascular; Female; Fibrosis; Heart Failure; Hemodynamics; Homocysteine; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Myocardium; Protein-Lysine 6-Oxidase; Tissue Inhibitor of Metalloproteinases; Ventricular Remodeling | 2008 |
Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice.
Topics: Animals; Collagen; Cystathionine beta-Synthase; Endothelium, Vascular; Genotype; Homocysteine; Hypertrophy, Left Ventricular; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Muscle Cells; Nitric Oxide Synthase Type II; Phenotype; Tyrosine; Ventricular Remodeling | 2009 |
Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart.
Topics: Adult; Dilatation, Pathologic; Female; Heart Ventricles; Homocysteine; Humans; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Middle Aged; Natriuretic Peptide, Brain; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Homocysteine; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Methionine; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2010 |
Cardiovascular disease and CKD: core curriculum 2010.
Topics: Acute Coronary Syndrome; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Cardiac Catheterization; Cardiovascular Diseases; Cholesterol, LDL; Comorbidity; Diabetic Nephropathies; Dyslipidemias; Electrocardiography; Heart Failure; Heart Valve Diseases; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Life Style; Myocardial Ischemia; Oxidative Stress; Pericarditis; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Smoking; Troponin T | 2010 |
Increased inflammatory markers are associated with obesity and not with target organ damage in newly diagnosed untreated essential hypertensive patients.
Topics: Adult; Aged; Albuminuria; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypertrophy, Left Ventricular; Inflammation Mediators; Male; Middle Aged; Obesity; Risk Factors | 2012 |
Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Pressure Determination; Cohort Studies; Echocardiography, Doppler; Female; Glomerular Filtration Rate; Heart Failure, Systolic; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome; Urination; Urine | 2013 |
Homocysteine, adrenergic activity and left ventricular mass in patients with essential hypertension.
Topics: Adult; Case-Control Studies; Chromatography, High Pressure Liquid; Echocardiography; Epinephrine; Female; Homocysteine; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Norepinephrine; Regression Analysis | 2002 |
Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
Topics: Adult; Arginine; Coronary Disease; Cystathionine; Female; Glycation End Products, Advanced; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Logistic Models; Lysine; Male; Methylmalonic Acid; Middle Aged; Risk Factors | 2003 |
Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.
Topics: Creatinine; Female; Hemoglobins; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Prevalence; Risk Factors; Vascular Diseases | 2003 |
Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cholesterol, LDL; Comorbidity; Female; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Hong Kong; Humans; Hypertrophy, Left Ventricular; Kidney; Kidney Failure, Chronic; Life Tables; Lipids; Male; Middle Aged; Mortality; Peritoneal Dialysis, Continuous Ambulatory; Proportional Hazards Models; Prospective Studies; Risk; Serum Albumin; Solubility; Survival Analysis; Treatment Outcome; Ultrasonography; Vascular Cell Adhesion Molecule-1 | 2005 |
Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
Topics: Adult; Cardiovascular Diseases; Carotid Arteries; Cytokines; Female; Genotype; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Transplantation; Lipoprotein(a); Male; Middle Aged; Polymorphism, Genetic; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tunica Intima | 2005 |
Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension.
Topics: Adolescent; Animals; Apolipoprotein A-I; Birth Weight; Blood Pressure; Carotid Arteries; Child; Child, Preschool; Female; Femoral Artery; Homocysteine; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Prognosis; Sodium; Tunica Intima; Tunica Media; Ultrasonography; Uric Acid | 2006 |
Platelet activity and serum homocysteine levels in patients with end-stage renal failure with regard to dialysis modality.
Topics: Aged; Analysis of Variance; Female; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; P-Selectin; Peritoneal Dialysis, Continuous Ambulatory; Platelet Activation; Renal Dialysis; Statistics, Nonparametric | 2006 |
The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Homocysteine; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2006 |
Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension.
Topics: Adiponectin; Adolescent; Body Mass Index; Child; Child, Preschool; Echocardiography; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Homocysteine; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin; Male; Metabolic Syndrome; Prognosis; Radioimmunoassay; Retrospective Studies; Risk Factors; Severity of Illness Index | 2008 |
A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage.
Topics: Adult; Aged; Echocardiography, Doppler; Endothelium, Vascular; Female; Follow-Up Studies; Homocysteine; Homocystinuria; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Pilot Projects; Prognosis; von Willebrand Factor | 2001 |
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, HDL; Cohort Studies; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus; Female; Hemoglobin A; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Peripheral Vascular Diseases; Prevalence; Prospective Studies | 2001 |
Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats.
Topics: Animals; Electrocardiography; Endocardium; Endothelium, Vascular; Fibrosis; Folic Acid; Heart Ventricles; Homocysteine; Hypertension; Hypertrophy, Left Ventricular; Matrix Metalloproteinases; Myocardium; Rats; Rats, Inbred SHR; Rats, Wistar; Ventricular Function, Left | 2002 |